Migergot
Product Images NDC 75987-090

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Migergot (NDC 75987-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Horizon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

One Suppository At Start Of Attack; Second Suppository After 1 Hour, If Needed For Full Relief. (Ergotamine Tartrate And Caffeine Suppositories Usp 02)

An instructional diagram showing two suppositories intended for rectal administration, depicting timing for use: one suppository at the start of an attack and a second suppository one hour later if needed for full relief.*

FDA Label Image

Principal Display Panelndc 75987-090-11migergotergotamine Tartrate And Caffeine Suppositories Usp12 Rectal Suppositoriesrx Only (Ergotamine Tartrate And Caffeine Suppositories Usp 03)

Migergot Suppositories box label showing product name Migergot with active ingredients Ergotamine Tartrate and Caffeine. The label states each rectal suppository contains Ergotamine Tartrate USP 2 mg, Caffeine USP 100 mg, and Tartaric Acid 21.5 mg. The package contains 12 rectal suppositories and is labeled Rx Only. Horizon Pharma Inc. is the labeler. Storage instructions to refrigerate at 2°- 8°C (36°- 46°F) are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.